The undesirable cardiotoxicity caused by CDK9 treatment requires extra vigilance, as the death of patients receiving targeted therapy is not limited to tumor occurrence and metastasis but fatal cardiovascular complications such as severe heart failure and malignant arrhythmia (35). The gene discussed is CDK9; the disease is heart failure.